Key result
Nebivolol evaluated for preventing left ventricular systolic dysfunction in Duchenne muscular dystrophy.
Evaluates nebivolol to prevent left ventricular systolic dysfunction in Duchenne muscular dystrophy, indicating potential early cardioprotective value.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Monzo et al. (2026) studied this question. Nebivolol was investigated for the prevention of left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: